Relx

RELX · LONDON

$40.54−$0.08 (−0.20%)TodayMarket closed ·
Prev close $40.62

About RELX

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. The firm operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.

Employees
36,660
Headquarters
London
Listed
Apr 21, 1948
Sector
Industrials
Industry
Professional Services
Website
relx.com

Leadership

Relx executives
NameTitleSince
Paul Walker——
Erik Engstrom—2004
Nicholas Luff—2014
Kumsal Besson——
Youngsuk Chi——
Hugh Jones——
Mark Kelsey—2020
Vijay Raghavan——
Mike Walsh——
Rosemary Thomson——
Shweta Vyas——
Henry Udow——
Andy Halford——
Alistair Cox——
June Felix——
Charlotte Hogg——
Andrew Sukawaty——
Bianca Tetteroo——
Suzanne Wood——
Colin Tennant——

Similar companies

Companies in the same industry as Relx

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.